Applied BioCode Corporation (TPE:6598)
21.95
+0.05 (0.23%)
Apr 29, 2026, 1:30 PM CST
Applied BioCode Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 464.79 | 605.96 | 413.19 | 831.32 | 646.07 | Upgrade
|
| Short-Term Investments | 104.8 | 251.53 | 191.62 | - | - | Upgrade
|
| Cash & Short-Term Investments | 569.59 | 857.49 | 604.82 | 831.32 | 646.07 | Upgrade
|
| Cash Growth | -33.58% | 41.78% | -27.25% | 28.67% | -23.80% | Upgrade
|
| Receivables | 121.98 | 45.02 | 51.04 | 70.81 | 67.81 | Upgrade
|
| Inventory | 156.29 | 190.07 | 174.97 | 106.68 | 101.37 | Upgrade
|
| Other Current Assets | 10.6 | 11.71 | 6.53 | 5.48 | 11.2 | Upgrade
|
| Total Current Assets | 858.46 | 1,104 | 837.36 | 1,014 | 826.45 | Upgrade
|
| Property, Plant & Equipment | 144.53 | 98.79 | 131.14 | 169.62 | 162.77 | Upgrade
|
| Other Intangible Assets | 0.09 | 1.8 | 6.02 | 10.38 | 13.43 | Upgrade
|
| Long-Term Deferred Tax Assets | 2.98 | 3.11 | 4.5 | 3.99 | 3.51 | Upgrade
|
| Other Long-Term Assets | 6.65 | 6.92 | 14.19 | 14.18 | 12.8 | Upgrade
|
| Total Assets | 1,013 | 1,215 | 993.21 | 1,212 | 1,019 | Upgrade
|
| Accounts Payable | 15.68 | 6.44 | 2.58 | 8.73 | 9.43 | Upgrade
|
| Accrued Expenses | 38.44 | 35.63 | 32.08 | 35.06 | 26.11 | Upgrade
|
| Current Portion of Leases | 20.79 | 17.26 | 16.35 | 15.66 | 14.2 | Upgrade
|
| Current Income Taxes Payable | 5.22 | 2.53 | 0.47 | 1.5 | 4.18 | Upgrade
|
| Current Unearned Revenue | 42.78 | 54.59 | 43.25 | 22.77 | 1.99 | Upgrade
|
| Other Current Liabilities | 3.64 | 13.38 | 6.84 | 3.91 | 4.05 | Upgrade
|
| Total Current Liabilities | 126.55 | 129.83 | 101.56 | 87.63 | 59.95 | Upgrade
|
| Long-Term Leases | 38.77 | 2.27 | 18.08 | 33.45 | 44.56 | Upgrade
|
| Long-Term Unearned Revenue | 201.2 | 200.87 | 208.08 | 271.33 | 7.99 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 2.98 | 3.11 | 4.5 | 3.99 | 3.51 | Upgrade
|
| Total Liabilities | 369.49 | 336.07 | 332.22 | 396.38 | 116.01 | Upgrade
|
| Common Stock | 1,028 | 1,028 | 817.68 | 817.63 | 817.29 | Upgrade
|
| Additional Paid-In Capital | 37.22 | 272.28 | 43.81 | 359.24 | 351.58 | Upgrade
|
| Retained Earnings | -417.81 | -453.97 | -193.16 | -349.93 | -165.2 | Upgrade
|
| Comprehensive Income & Other | -4.31 | 32.65 | -7.34 | -10.88 | -100.71 | Upgrade
|
| Shareholders' Equity | 643.22 | 878.83 | 660.99 | 816.07 | 902.96 | Upgrade
|
| Total Liabilities & Equity | 1,013 | 1,215 | 993.21 | 1,212 | 1,019 | Upgrade
|
| Total Debt | 59.56 | 19.52 | 34.43 | 49.11 | 58.76 | Upgrade
|
| Net Cash (Debt) | 510.03 | 837.96 | 570.39 | 782.21 | 587.31 | Upgrade
|
| Net Cash Growth | -39.13% | 46.91% | -27.08% | 33.18% | -25.32% | Upgrade
|
| Net Cash Per Share | 4.96 | 9.25 | 6.98 | 9.57 | 7.19 | Upgrade
|
| Filing Date Shares Outstanding | 102.81 | 102.79 | 81.77 | 81.76 | 81.73 | Upgrade
|
| Total Common Shares Outstanding | 102.81 | 102.79 | 81.77 | 81.76 | 81.73 | Upgrade
|
| Working Capital | 731.92 | 974.46 | 735.8 | 926.66 | 766.5 | Upgrade
|
| Book Value Per Share | 6.26 | 8.55 | 8.08 | 9.98 | 11.05 | Upgrade
|
| Tangible Book Value | 643.13 | 877.03 | 654.97 | 805.69 | 889.52 | Upgrade
|
| Tangible Book Value Per Share | 6.26 | 8.53 | 8.01 | 9.85 | 10.88 | Upgrade
|
| Machinery | 84.49 | 78.54 | 70.92 | 67.91 | 91.96 | Upgrade
|
| Construction In Progress | - | - | 1.4 | 17.9 | 1.01 | Upgrade
|
| Leasehold Improvements | 72.34 | 75.3 | 70.79 | 52.29 | 46.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.